<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000642135">
  <TermName>1-(2’-deoxy-2’-fluoro-β-D-arabinofuranosyl) uracil</TermName>
  <TermPronunciation>(1-(2'-dee-OK-see-2'-FLOOR-oh-BAY-tuh-D-uh-RA-bih-noh-fyoor-A-noh-sil) YOOR-uh-sil)</TermPronunciation>
  <TermDefinition>
    <DefinitionText>A substance being studied in the treatment of advanced solid tumors and lymphomas. It blocks the growth of cells and may cause cancer cells to die. It is a type of uracil analog. Also called FAU.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <MediaLink ref="CDR0000723011" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;1-(2’-deoxy-2’-fluoro-β-D-arabinofuranosyl) uracil&quot;" language="en" id="_3"/>
  <MediaLink ref="CDR0000723010" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;1-(2-desoxi-2-fluoro-β-D-arabinofuranosil)-uracilo&quot;" language="es" id="_4"/>
  <SpanishTermName>1-(2’-desoxi-2’-fluoro-β-D-arabinofuranosil)uracilo</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Sustancia en estudio para el tratamiento de los tumores sólidos y los linfomas en estadio avanzado. Impide la multiplicación de las células y es posible que destruya células cancerosas. Es un tipo de análogo del uracilo. También se llama FAU.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <DateFirstPublished>2009-07-21</DateFirstPublished>
</GlossaryTerm>
